Copperwynd Financial LLC Sells 40 Shares of Axon Enterprise, Inc $AXON

Copperwynd Financial LLC lessened its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 6.9% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 537 shares of the biotechnology company’s stock after selling 40 shares during the period. Copperwynd Financial LLC’s holdings in Axon Enterprise were worth $445,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in AXON. Brighton Jones LLC bought a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $480,000. Wedmont Private Capital boosted its stake in shares of Axon Enterprise by 22.8% in the first quarter. Wedmont Private Capital now owns 825 shares of the biotechnology company’s stock valued at $469,000 after buying an additional 153 shares during the period. Capital Investment Advisors LLC boosted its stake in shares of Axon Enterprise by 86.5% in the first quarter. Capital Investment Advisors LLC now owns 1,285 shares of the biotechnology company’s stock valued at $676,000 after buying an additional 596 shares during the period. Yousif Capital Management LLC boosted its stake in shares of Axon Enterprise by 1.6% in the first quarter. Yousif Capital Management LLC now owns 9,961 shares of the biotechnology company’s stock valued at $5,239,000 after buying an additional 157 shares during the period. Finally, Harbor Capital Advisors Inc. bought a new stake in shares of Axon Enterprise in the first quarter valued at approximately $587,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AXON. Needham & Company LLC reiterated a “buy” rating and issued a $870.00 price target on shares of Axon Enterprise in a research note on Wednesday, September 24th. Northland Securities set a $800.00 target price on Axon Enterprise in a research note on Tuesday, August 5th. Raymond James Financial restated an “outperform” rating and set a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Finally, Bank of America upped their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $841.64.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Hadi Partovi acquired 1,358 shares of the firm’s stock in a transaction that occurred on Wednesday, August 13th. The stock was bought at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the completion of the acquisition, the director directly owned 237,938 shares of the company’s stock, valued at $176,074,120. This trade represents a 0.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is owned by company insiders.

Axon Enterprise Stock Up 1.8%

Shares of NASDAQ:AXON opened at $727.41 on Thursday. The company has a fifty day moving average of $756.79 and a 200-day moving average of $710.65. The company has a market capitalization of $57.10 billion, a PE ratio of 179.61, a price-to-earnings-growth ratio of 27.75 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52-week low of $422.21 and a 52-week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. The company had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.